Non small cell lung cancer chemotherapy: Difference between revisions
Jump to navigation
Jump to search
| (19 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Non small cell lung cancer}} | {{Non small cell lung cancer}} | ||
{{CMG}}; {{AE}} {{Alonso}} | {{CMG}}; {{AE}} {{Alonso}} {{MV}} | ||
==Overview== | ==Overview== | ||
Chemotherapeutic regimens are based on platinum agents such as [[cisplatin]], [[carboplatin]], [[oxaliplatin]], and [[satraplatin]]. Alternative regimens include [[paclitaxel]], [[gemcitabine]], or [[etoposide]]. Chemotherapeutic regimens are adjusted based on individual characteristics and body surface. The regimen adjustment according to tumor evolution has demonstrated longer survival rates, optimal symptom control, and higher quality of life. | |||
==Chemotherapeutic | ==Chemotherapeutic Regimens== | ||
Shown below is a table depicting the different choices of regimens for the initial or adjuvant chemotherapy of patients with non-small cell lung cancer. The list of regimens has been adapted from the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | Shown below is a table depicting the different choices of regimens for the initial or adjuvant chemotherapy of patients with non-small cell lung cancer. The list of regimens has been adapted from the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="lungcancer">Alberti, W; Anderson, G; Bartolucci, A; Bell, D; et al. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. British Medical Journal, International edition311.7010 (Oct 7, 1995): 899 </ref><ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | ||
===Cisplatin Based Therapy=== | ===Cisplatin Based Therapy=== | ||
{| | {| border="1" | ||
|- | |- | ||
! Agent !! Recommended regimen | ! Agent !! Recommended regimen | ||
| Line 32: | Line 33: | ||
|} | |} | ||
===Alternative Regimen | ===Alternative Regimen=== | ||
Paclitaxel 200 mg/m<sup>2</sup> on day 1 + carboplatin area under the concentration (AUC) 6 on day 1 and then every 21 days.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | [[Paclitaxel]] 200 mg/m<sup>2</sup> on day 1 + [[carboplatin]] area under the concentration (AUC) 6 on day 1 and then every 21 days.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | ||
==Chemotherapy with | ==Chemotherapy with Radiation Therapy Regimens== | ||
===Chemotherapy plus Radiation Therapy=== | ===Chemotherapy plus Radiation Therapy=== | ||
The list bellow show the options for concomitant [[chemotherapy]] plus [[radiation therapy]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | The list bellow show the options for concomitant [[chemotherapy]] plus [[radiation therapy]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | ||
*[[Cisplatin]] 50 mg/m<sup>2</sup> on days 1, 8, 29 and 36 + [[etoposide]] 50 mg/m<sup>2</sup> through days 1 to 5 and then 29 to 33 + thoracic | *[[Cisplatin]] 50 mg/m<sup>2</sup> on days 1, 8, 29 and 36 + [[etoposide]] 50 mg/m<sup>2</sup> through days 1 to 5 and then 29 to 33 + [[Non small cell carcinoma of the lung radiation therapy|thoracic radiation therapy]] | ||
*[[Cisplatin]] 100 mg/m<sup>2</sup> on days 1 and 29 + | *[[Cisplatin]] 100 mg/m<sup>2</sup> on days 1 and 29 + [[vinblastine]] 5 mg/m<sup>2</sup> weekly for 5 weeks + [[Non small cell carcinoma of the lung radiation therapy|thoracic radiation therapy]] | ||
*[[Cisplatin]] 75 mg/m<sup>2</sup> on the first day + [[pemetrexed]] 500 mg/m<sup>2</sup> on day 1 and then every 21 days to a total of 3 cycles + thoracic | *[[Cisplatin]] 75 mg/m<sup>2</sup> on the first day + [[pemetrexed]] 500 mg/m<sup>2</sup> on day 1 and then every 21 days to a total of 3 cycles + [[Non small cell carcinoma of the lung radiation therapy|thoracic radiation therapy]] | ||
*Carboplatin | *[[Carboplatin]] AUC 5 on the first day + [[pemetrexed]] 500 mg/m<sup>2</sup> on day 1 and then every 21 days to a total of 3 cycles + [[Non small cell carcinoma of the lung radiation therapy|thoracic radiation therapy]] | ||
===Chemotherapy Followed by Radiation Therapy=== | ===Chemotherapy Followed by Radiation Therapy=== | ||
The list bellow show the options for [[chemotherapy]] followed by [[radiation therapy]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | The list bellow show the options for [[chemotherapy]] followed by [[radiation therapy]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | ||
* [[Cisplatin]] 100 mg/m<sup>2</sup> on days 1 and 29 + | * [[Cisplatin]] 100 mg/m<sup>2</sup> on days 1 and 29 + [[vinblastine]] 5 mg/m<sup>2</sup> per week on days 1, 8, 15, 22 and 29 followed by [[Non small cell carcinoma of the lung radiation therapy|thoracic radiation therapy]]. | ||
* [[Paclitaxel]] 200 mg/m<sup>2</sup> administered for 3 hours in the first day + carboplatin AUC 6 administered in 1 hour and then every 21 days to a total of 2 cycles followed by thoracic radiation therapy. | * [[Paclitaxel]] 200 mg/m<sup>2</sup> administered for 3 hours in the first day + carboplatin AUC 6 administered in 1 hour and then every 21 days to a total of 2 cycles followed by [[Non small cell carcinoma of the lung radiation therapy|thoracic radiation therapy]]. | ||
===Chemotherapy plus Radiation Therapy, Followed by Chemotherapy=== | ===Chemotherapy plus Radiation Therapy, Followed by Chemotherapy=== | ||
The list bellow show the options for concomitant [[chemotherapy]] plus [[radiation therapy]] followed by [[chemotherapy]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | The list bellow show the options for concomitant [[chemotherapy]] plus [[radiation therapy]] followed by [[chemotherapy]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | ||
* Cisplatin 50 mg/m<sup>2</sup> on days 1, 8, 29 and 36 + etoposide 50 mg/m<sup>2</sup> through day 1 to 5 and then 29 to 33 + thoracic radiation therapy, then followed by cisplatin 50 mg/m<sup>2</sup> + etoposide 50 mg/m<sup>2</sup> to a total of 2 cycles. | * [[Cisplatin]] 50 mg/m<sup>2</sup> on days 1, 8, 29 and 36 + [[etoposide]] 50 mg/m<sup>2</sup> through day 1 to 5 and then 29 to 33 + [[Non small cell carcinoma of the lung radiation therapy|thoracic radiation therapy]], then followed by [[cisplatin]] 50 mg/m<sup>2</sup> + [[etoposide]] 50 mg/m<sup>2</sup> to a total of 2 cycles. | ||
* Paclitaxel 45 to 50 mg/m<sup>2</sup> once a week + carboplatin AUC 2 + thoracic radiation therapy, then followed by [[Paclitaxel]] 200 mg/m<sup>2</sup> + carboplatin AUC 6 to a total of 2 cycles. | * [[Paclitaxel]] 45 to 50 mg/m<sup>2</sup> once a week + carboplatin AUC 2 + [[Non small cell carcinoma of the lung radiation therapy|thoracic radiation therapy]], then followed by [[Paclitaxel]] 200 mg/m<sup>2</sup> + [[carboplatin]] AUC 6 to a total of 2 cycles. | ||
==References== | ==References== | ||
| Line 64: | Line 65: | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Lung cancer]] | [[Category:Lung cancer]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | |||
[[Category:Pulmonology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 23:35, 23 February 2018
|
Non Small Cell Lung Cancer Microchapters |
|
Differentiating Non Small Cell Lung Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non small cell lung cancer chemotherapy On the Web |
|
American Roentgen Ray Society Images of Non small cell lung cancer chemotherapy |
|
Directions to Hospitals Treating Non small cell carcinoma of the lung |
|
Risk calculators and risk factors for Non small cell lung cancer chemotherapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2] Maria Fernanda Villarreal, M.D. [3]
Overview
Chemotherapeutic regimens are based on platinum agents such as cisplatin, carboplatin, oxaliplatin, and satraplatin. Alternative regimens include paclitaxel, gemcitabine, or etoposide. Chemotherapeutic regimens are adjusted based on individual characteristics and body surface. The regimen adjustment according to tumor evolution has demonstrated longer survival rates, optimal symptom control, and higher quality of life.
Chemotherapeutic Regimens
Shown below is a table depicting the different choices of regimens for the initial or adjuvant chemotherapy of patients with non-small cell lung cancer. The list of regimens has been adapted from the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[1][2]
Cisplatin Based Therapy
| Agent | Recommended regimen |
|---|---|
| Cisplatin 50 mg/m2 + vinorelbine 25 mg/m2 | Cisplatin on days 1 and 8, vinorelbine on days 1, 8, 15, 22 and every 28 days to a total of 4 cycles |
| Cisplatin 100 mg/m2 + vinorelbine 30 mg/m2 | Cisplatin on day 1, vinorelbine on days 1, 8, 15, 22 and every 28 days to a total of 4 cycles |
| Cisplatin 75-80 mg/m2 + vinorelbine 25-50 mg/m2 | Cisplatin on day 1, vinorelbine on days 1, 8 and every 21 days to a total of 4 cycles |
| Cisplatin 80 mg/m2 + vinorelbine 4 mg/m2 | Cisplatin on days 1, 22, 43, 64, then every 21 days to a total of 4 cycles, vinorelbine on days 1, 8, 15, 22, 29, every 2 weeks after day 43 until the completion of cisplatin treatmet |
| Cisplatin 100 mg/m2 + etoposide 100 mg/m2 | Cisplatin on day 1, etoposide through days 1 to 3 and every 28 days to a total of 4 cycles |
| Cisplatin 75 mg/m2 + gemcitabine 1250 mg/m2 | Cisplatin on day 1, gemcitabine on days 1, 8 and every 21 days to a total of 4 cycles |
| Cisplatin 75 mg/m2 + docetaxel 75 mg/m2 | Cisplatin on day 1, docetaxel on day 1 and every 21 days to a total of 4 cycles |
| Cisplatin 50 mg/m2 + pemetrexed 500 mg/m2 | Cisplatin on day 1, pemetrexed on days 1 and every 21 days to a total of 4 cycles |
Alternative Regimen
Paclitaxel 200 mg/m2 on day 1 + carboplatin area under the concentration (AUC) 6 on day 1 and then every 21 days.[2]
Chemotherapy with Radiation Therapy Regimens
Chemotherapy plus Radiation Therapy
The list bellow show the options for concomitant chemotherapy plus radiation therapy based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[2]
- Cisplatin 50 mg/m2 on days 1, 8, 29 and 36 + etoposide 50 mg/m2 through days 1 to 5 and then 29 to 33 + thoracic radiation therapy
- Cisplatin 100 mg/m2 on days 1 and 29 + vinblastine 5 mg/m2 weekly for 5 weeks + thoracic radiation therapy
- Cisplatin 75 mg/m2 on the first day + pemetrexed 500 mg/m2 on day 1 and then every 21 days to a total of 3 cycles + thoracic radiation therapy
- Carboplatin AUC 5 on the first day + pemetrexed 500 mg/m2 on day 1 and then every 21 days to a total of 3 cycles + thoracic radiation therapy
Chemotherapy Followed by Radiation Therapy
The list bellow show the options for chemotherapy followed by radiation therapy based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[2]
- Cisplatin 100 mg/m2 on days 1 and 29 + vinblastine 5 mg/m2 per week on days 1, 8, 15, 22 and 29 followed by thoracic radiation therapy.
- Paclitaxel 200 mg/m2 administered for 3 hours in the first day + carboplatin AUC 6 administered in 1 hour and then every 21 days to a total of 2 cycles followed by thoracic radiation therapy.
Chemotherapy plus Radiation Therapy, Followed by Chemotherapy
The list bellow show the options for concomitant chemotherapy plus radiation therapy followed by chemotherapy based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[2]
- Cisplatin 50 mg/m2 on days 1, 8, 29 and 36 + etoposide 50 mg/m2 through day 1 to 5 and then 29 to 33 + thoracic radiation therapy, then followed by cisplatin 50 mg/m2 + etoposide 50 mg/m2 to a total of 2 cycles.
- Paclitaxel 45 to 50 mg/m2 once a week + carboplatin AUC 2 + thoracic radiation therapy, then followed by Paclitaxel 200 mg/m2 + carboplatin AUC 6 to a total of 2 cycles.
References
- ↑ Alberti, W; Anderson, G; Bartolucci, A; Bell, D; et al. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. British Medical Journal, International edition311.7010 (Oct 7, 1995): 899
- ↑ 2.0 2.1 2.2 2.3 2.4 http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf